Clinical trial
Phase 2/3 Clinical Study With BLM-240 in Adult Surgery Patients That Need General Anesthesia
NCT00762372 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2/3 Clinical Study With BLM-240 in Adult Surgery Patients That Need General Anesthesia
- Lead sponsor
- Baxter Healthcare Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- August 31, 2008
- Enrollment
- 216 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia